Shame and stigma in association with the HCV cascade to cure among people who inject drugs

The shame spiral of addiction: Negative self-conscious emotion and substance use

(2022) Abigail W. Batchelder et al.   PLoS One

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

(2022) Alain H Litwin et al.   Lancet Gastroenterology & Hepatology

Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City

(2021) Brandon Muncan et al.   SUBSTANCE USE & MISUSE

Intersecting internalized stigmas and HIV self-care among men who have sex with men and who use substances

(2021) Abigail W. Batchelder et al.   SOCIAL SCIENCE & MEDICINE

Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis

(2021) Afia Amoako et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs

(2021) Trevor Goodyear et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes

(2019) Avy A. Skolnik et al.   BMC HEALTH SERVICES RESEARCH

Intervention stigma: How medication-assisted treatment marginalizes patients and providers

(2019) Erin Fanning Madden   SOCIAL SCIENCE & MEDICINE

Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study

(2019) Alain H. Litwin et al.   Contemporary Clinical Trials

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

(2019) Marc G. Ghany et al.   HEPATOLOGY

‘Hep C’s like the common cold’: Understanding barriers along the HCV care continuum among young people who inject drugs

(2018) Margie R. Skeer et al.   DRUG AND ALCOHOL DEPENDENCE

Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

(2018) Megan G. Hofmeister et al.   HEPATOLOGY

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

(2017) Jason Grebely et al.   Journal of the International AIDS Society

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

(2017) Louisa Degenhardt et al.   Lancet Global Health

Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals

(2016) Zachary C. Rich et al.   BMC PUBLIC HEALTH

“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment

(2015) A.W. Batchelder et al.   DRUG AND ALCOHOL DEPENDENCE

HIV Stigma Among Substance Abusing People Living with HIV/AIDS: Implications for HIV Treatment

(2014) Maria A. Levi-Minzi et al.   AIDS PATIENT CARE AND STDS

Barriers and Facilitators to Medication Adherence in a Southern Minority Population With HIV Disease

(2008) Deborah J. Konkle-Parker et al.   JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE